Patents by Inventor Hilde Riethmüller-Winzen

Hilde Riethmüller-Winzen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for the treatment of fertility disorders
    Patent number: 6319192
    Abstract: An improvement to the method of intrauterine insemination by the administration of luteinizing hormone-releasing hormone antagonists (LHRH antagonists).
    Type: Grant
    Filed: April 23, 1999
    Date of Patent: November 20, 2001
    Assignee: Zentaris AG
    Inventors: Jürgen Engel, Hilde Riethmüller-Winzen, Thomas Reissmann
  • Means for treating prostate hypertrophy and prostate cancer
    Patent number: 6300313
    Abstract: A regime for therapeutic management of a benign prostatic hyperplasia and prostatic cancer employs Cetrorelix alone or in combination with &agr;-reductase inhibitors or &agr;-receptor blocking agents. The regiment reduces the volume of the prostate and avoids the side effects associated with testosterone levels being in a castration range. Cetrorelix is administered at dosages between 0.5 mg/day and 20 mg/week or about 0.014 mg/kg body weight per day to 0.30 mg/kg body weight per week or at levels of about 25 to 120 mg of Cetrorelix per month or 0.376 mg/kg to 1.71 mg/kg per month. Cetrorelix can be administered with &agr;-reductase inhibitors or a &agr;-receptor blocking agents.
    Type: Grant
    Filed: September 22, 1999
    Date of Patent: October 9, 2001
    Assignee: ASTA Medica Aktiengesellschaft
    Inventors: Jürgen Engel, Thomas Reissmann, Hilde Riethmüller-Winzen, Jürgen Rawert